You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Suppliers and packagers for CETIRIZINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


CETIRIZINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Amneal Pharms CETIRIZINE HYDROCHLORIDE cetirizine hydrochloride SOLUTION;ORAL 090766 ANDA Amneal Pharmaceuticals LLC 65162-684-86 118 mL in 1 BOTTLE (65162-684-86) 2009-10-07
Amneal Pharms CETIRIZINE HYDROCHLORIDE cetirizine hydrochloride SOLUTION;ORAL 090766 ANDA Amneal Pharmaceuticals LLC 65162-684-90 473 mL in 1 BOTTLE (65162-684-90) 2009-10-07
Apozeal Pharms CETIRIZINE HYDROCHLORIDE cetirizine hydrochloride SOLUTION;ORAL 078870 ANDA Preferred Pharmaceuticals Inc. 68788-8890-1 120 mL in 1 BOTTLE (68788-8890-1) 2025-06-27
Apozeal Pharms CETIRIZINE HYDROCHLORIDE cetirizine hydrochloride SOLUTION;ORAL 078870 ANDA APOZEAL PHARMACEUTICALS INC 83745-185-04 120 mL in 1 BOTTLE (83745-185-04) 2024-12-20
Apozeal Pharms CETIRIZINE HYDROCHLORIDE cetirizine hydrochloride SOLUTION;ORAL 078870 ANDA APOZEAL PHARMACEUTICALS INC 83745-185-08 240 mL in 1 BOTTLE (83745-185-08) 2024-12-20
Apozeal Pharms CETIRIZINE HYDROCHLORIDE cetirizine hydrochloride SOLUTION;ORAL 078870 ANDA APOZEAL PHARMACEUTICALS INC 83745-185-16 480 mL in 1 BOTTLE (83745-185-16) 2024-12-20
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: CETIRIZINE HYDROCHLORIDE

Last updated: July 29, 2025


Introduction

CETIRIZINE HYDROCHLORIDE remains among the top antihistamines favored worldwide for allergy relief. Known for its efficacy in managing hay fever, urticaria, and allergic rhinitis, the compounded demand for cetirizine hydrochloride drives significant industry activity. Industrial stakeholders—from pharmaceutical manufacturers to generic drug producers—rely on a diverse pool of raw material suppliers to ensure high-quality manufacturing. This comprehensive review explores the primary suppliers, market dynamics, manufacturing standards, and strategic sourcing considerations for cetirizine hydrochloride.


Market Overview of Cetirizine Hydrochloride Suppliers

The global supply chain for cetirizine hydrochloride includes a combination of large chemical producers, generic drug manufacturers, and regional suppliers. The primary manufacturing hubs are located in China, India, and Europe—regions recognized for their capacity in bulk pharmaceutical chemicals. These suppliers differentiate based on quality certifications, production capacity, regulatory compliance, and cost efficiency.

Major Suppliers and Manufacturers

1. Chinese Chemical Producers

China dominates the production landscape, accounting for the majority of worldwide cetirizine hydrochloride raw material supply.

  • Shandong East Chemical Co., Ltd.
    A notable producer offering APIs with cGMP certification, East Chemical supplies various antihistamines, including cetirizine hydrochloride, catering to both domestic and export markets.

  • Hefei TNJ Chemical Industry Co., Ltd.
    Specializes in the manufacturing of pharmaceutical intermediates and APIs with consistent quality assurance and GMP compliance.

  • Zhejiang Huahai Pharmaceutical Co., Ltd.
    A leading API manufacturer with a diversified portfolio that includes cetirizine hydrochloride, emphasizing rigorous quality controls and regulatory adherence.

2. Indian API Manufacturers

India's strong pharmaceutical sector provides high-quality cetirizine hydrochloride raw materials as well as finished dosage forms.

  • Mundipharma India Pvt Ltd.
    Known for manufacturing and exporting APIs, including cetirizine hydrochloride, adhering to strict Indian regulations and international standards.

  • Alkem Laboratories Ltd.
    A prominent pharmaceutical company producing APIs and formulations, with a robust export network.

  • States or regional suppliers such as GVK Biosciences (GVK BIO) often supply intermediates and APIs to global customers in compliance with global regulatory standards.

3. European Manufacturers

European API producers tend to serve markets demanding stringent quality controls and regulatory sustenance.

  • Siegfried AG (Switzerland)
    Offers APIs including cetirizine hydrochloride, focusing on high-purity standards and GMP certifications.

  • Generics companies with local manufacturing facilities in Germany or Eastern Europe ensure regional supply chains and compliance with EU regulations.


Key Factors Influencing Supplier Selection

  • Regulatory Compliance: Suppliers with GMP, EMA, FDA certifications, and validated manufacturing processes are preferred for quality assurance and market access.

  • Production Capacity: Large-scale manufacturers can fulfill bulk orders essential for global distribution.

  • Pricing and Contract Flexibility: Competitive pricing structures, combined with flexible supply agreements, are advantageous amid fluctuating demand.

  • Supply Chain Reliability: Proven track record of delivery timeliness and quality consistency reduces operational risks.

  • Technological Capabilities: Suppliers employing advanced synthesis methods and purification techniques enhance API purity levels essential for pharmaceutical standards.

Supply Chain Challenges and Mitigation Strategies

  • Market Concentration Risks: Heavy reliance on a few Chinese suppliers exposes buyers to geopolitical and supply chain disruptions. Diversification strategies including regional sourcing mitigate such risks.

  • Regulatory Barriers: Variations in regional regulations necessitate compliance verification before procurement. Partnering with suppliers holding multiple certification attestations is advisable.

  • Price Volatility: Raw material scarcity or production constraints can impact prices. Long-term contracts provide pricing stability.

  • Quality Variability: Rigorous auditing, batch testing, and supplier accreditation ensure API quality and regulatory compliance.


Regulatory and Quality Standards

Suppliers must comply with global standards such as:

  • Good Manufacturing Practices (GMP)
  • ISO Certification
  • FDA Registration for US markets
  • EMA Certification for European markets

Regular audits by buyers and regulatory agencies are critical for maintaining supplier credibility and API quality. Certification documents and batch test reports are essential documentation during procurement negotiations.


Emerging Trends and Future Outlook

The rising focus on biosimilar and generic markets propels demand for cetirizine hydrochloride. Suppliers investing in sustainable manufacturing practices, such as green chemistry and waste minimization, gain competitive advantage. Additionally, digital traceability systems are increasingly employed for quality assurance and transparency.

The industry anticipates further consolidation among suppliers to meet global regulatory requirements and produce at scale while maintaining cost efficiency. Alternative sourcing from regions with skilled manufacturing bases, like Southeast Asia or Eastern Europe, is gaining traction to diversify supply chains.


Key Takeaways

  • Supplier diversity is crucial. Relying solely on Chinese API manufacturers exposes firms to geopolitical and logistical risks. Incorporating suppliers from India and Europe ensures supply stability.

  • Regulatory compliance dictates supplier choice. GMP certification and regulatory approvals serve as non-negotiable benchmarks for quality assurance.

  • Capacity and reliability are paramount. Large-volume manufacturers with proven delivery histories underpin operational continuity.

  • Pricing strategies should balance cost and quality. Competitive pricing must not compromise API purity, which is vital for market acceptance.

  • Supply chain resilience demands proactive risk management. Establishing long-term partnerships, contract flexibility, and regional sourcing buffers mitigate disruptions.


FAQs

1. Who are the leading global suppliers of cetirizine hydrochloride API?
China-based companies such as Zhejiang Huahai Pharmaceutical, Hefei TNJ Chemical, and Shandong East Chemical dominate supply. Indian firms like Alkem Laboratories and Mundipharma India also offer high-quality APIs, alongside European producers like Siegfried AG.

2. What regulatory certifications should suppliers possess for international markets?
Suppliers should have GMP certification, with additional FDA registration or EMA approval as applicable. Validated manufacturing processes and batch testing reports are essential for compliance.

3. How does supplier diversification impact supply chain stability?
Diversifying sourcing across regional suppliers reduces dependency on a single country, thereby minimizing risks related to geopolitical issues, pandemics, or supply restrictions, ensuring uninterrupted API availability.

4. What are the key factors to consider when selecting a cetirizine hydrochloride supplier?
Regulatory compliance, production capacity, price, supply reliability, quality certifications, and technological capabilities are critical selection criteria.

5. Are there risks associated with sourcing from Chinese manufacturers?
Yes. Geopolitical tensions, trade restrictions, and quality assurance concerns pose risks. Engaging with multiple suppliers and verifying certifications can mitigate these risks.


References

[1] Industry reports on pharmaceutical raw material suppliers.
[2] Global Pharmaceutical API Market Analysis, 2022.
[3] Regulatory standards for pharmaceutical APIs, WHO and FDA guidelines.
[4] Public disclosures and certifications of core suppliers.
[5] Industry insights on supply chain diversification in pharmaceuticals.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.